CGON (STOCKS)
CG Oncology, Inc. Common stock
$61.080000
+0.650000 (+1.08%)
Prev close: $60.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arthur Kuan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,382.12M
- Employees
- 113
- P/E (TTM)
- -26.08
- P/B (TTM)
- 4.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
15
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.71 | $-0.59 | -0.1203 | -20.40% |
|
Dec 2025 (Q4)
|
$-0.53 | $-0.63 | +0.0967 | +15.43% |
|
Sep 2025 (Q3)
|
$-0.57 | $-0.57 | +0.0012 | +0.21% |
|
Jun 2025 (Q2)
|
$-0.54 | $-0.47 | -0.0717 | -15.31% |
Financial Statements
| Revenues | $5.07M |
| Benefits Costs and Expenses | $26.78M |
| Costs And Expenses | $221.60M |
| Nonoperating Income/Loss | $28.21M |
| Operating Expenses | $220.03M |
| Research and Development | $132.90M |
| Other Operating Expenses | $87.13M |
| Operating Income/Loss | -$214.96M |
| Income/Loss From Continuing Operations After Tax | -$186.75M |
| Income/Loss From Continuing Operations Before Tax | $23.76M |
| Net Income/Loss | -$186.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$186.75M |
| Net Income/Loss Available To Common Stockholders, Basic | -$186.75M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.33 |
| Diluted Earnings Per Share | -$2.33 |
| Basic Average Shares | 238,395,131 |
| Diluted Average Shares | 238,395,131 |
| Assets | $1.14B |
| Current Assets | $1.10B |
| Accounts Receivable | $1.28M |
| Inventory | $1.49M |
| Other Current Assets | $1.10B |
| Noncurrent Assets | $33.12M |
| Fixed Assets | $15.07M |
| Other Non-current Assets | $18.05M |
| Liabilities | $43.48M |
| Current Liabilities | $35.22M |
| Accounts Payable | $8.24M |
| Other Current Liabilities | $26.98M |
| Noncurrent Liabilities | $8.27M |
| Equity | $1.09B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.09B |
| Liabilities And Equity | $1.14B |
| Net Cash Flow From Operating Activities | -$160.01M |
| Net Cash Flow From Operating Activities, Continuing | -$160.01M |
| Net Cash Flow From Investing Activities | -$393.90M |
| Net Cash Flow From Investing Activities, Continuing | -$393.90M |
| Net Cash Flow From Financing Activities | $546.14M |
| Net Cash Flow From Financing Activities, Continuing | $546.14M |
| Net Cash Flow | -$7.77M |
| Net Cash Flow, Continuing | -$7.77M |
| Comprehensive Income/Loss | -$186.75M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$186.75M |
| Other Comprehensive Income/Loss | $0.00 |